The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia
Open Access
- 14 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 21 (1), 1-10
- https://doi.org/10.1186/s12879-021-06669-5
Abstract
The prognosis of patients hospitalized with community-acquired pneumonia (CAP) with regards to intensive care unit (ICU) admission, short- and long-term mortality is correlated with patient’s comorbidities. For patients hospitalized for CAP, including P-CAP, we assessed the prognostic impact of comorbidities known as at-risk (AR) or high-risk (HR) of pneumococcal CAP (P-CAP), and of the number of combined comorbidities. Data on hospitalizations for CAP among the French 50+ population were extracted from the 2014 French Information Systems Medicalization Program (PMSI), an exhaustive national hospital discharge database maintained by the French Technical Agency of Information on Hospitalization (ATIH). Their admission diagnosis, comorbidities (nature, risk type and number), other characteristics, and their subsequent hospital stays within the year following their hospitalization for CAP were analyzed. Logistic regression models were used to assess the associations between ICU transfer, short- and 1-year in-hospital mortality and all covariates. From 182,858 patients, 149,555 patients aged ≥ 50 years (nonagenarians 17.8%) were hospitalized for CAP in 2014, including 8270 with P-CAP. Overall, 33.8% and 90.5% had ≥ 1 HR and ≥ 1 AR comorbidity, respectively. Cardiac diseases were the most frequent AR comorbidity (all CAP: 77.4%). Transfer in ICU occurred for 5.4% of CAP patients and 19.4% for P-CAP. Short-term and 1-year in-hospital mortality rates were 10.9% and 23% of CAP patients, respectively, significantly lower for P-CAP patients: 9.2% and 19.8% (HR 0.88 [95% CI 0.84–0.93], p < .0001). Both terms of mortality increased mostly with age, and with the number of comorbidities and combination of AR and HR comorbidities, in addition of specific comorbidities. Not only specific comorbidities, but also the number of combined comorbidities and the combination of AR and HR comorbidities may impact the outcome of hospitalized CAP and P-CAP patients.Funding Information
- Pfizer France
This publication has 33 references indexed in Scilit:
- Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic TechniquesPLOS ONE, 2013
- Multimorbidity and comorbidity in the Dutch population – data from general practicesBMC Public Health, 2012
- Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009JAMA, 2012
- Aging Population and Future Burden of Pneumococcal Pneumonia in the United StatesThe Journal of Infectious Diseases, 2012
- Multimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor AnalysisPLOS ONE, 2012
- Increased risk of invasive pneumococcal disease in haematological and solid-organ malignanciesEpidemiology and Infection, 2010
- Long-Term Morbidity and Mortality After Hospitalization With Community-Acquired PneumoniaMedicine, 2008
- Accuracy of Administrative Data for Identifying Patients With PneumoniaAmerican Journal of Medical Quality, 2005
- Assessment of Mortality after Long-Term Follow-Up of Patients with Community-Acquired PneumoniaClinical Infectious Diseases, 2003
- PneumoniaArchives of Internal Medicine, 2003